Sugi Predict

Sugi Predict / Compounds / SCHEMBL29613221

SCHEMBL29613221

SCHEMBL29613221

CC(C)[C@H](NS(=O)(=O)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC1A3 P43003 1/20 0.57
▸ SLC1A2 P43004 1/20 0.57
▸ SLC1A1 P43005 1/20 0.57
▸ LTA4H P09960 3/20 0.49
▸ MME P08473 2/20 0.49
▸ CCR1 P32246 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ACE P12821 5/20 0.46
▸ ANPEP P15144 1/20 0.46
▸ ECE1 P42892 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4330661 0.86 SLC1A3 (0.70) SLC1A3SLC1A2SLC1A1CCR1MEN1
SCHEMBL4330656 0.86 SLC1A3 (0.70) SLC1A3SLC1A2SLC1A1CCR1MEN1
SCHEMBL6626990 0.86 SLC1A3 (0.70) SLC1A3SLC1A2SLC1A1CCR1MEN1
SCHEMBL16821240 0.83 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1LTA4HMME
SCHEMBL6830160 0.83 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1LTA4HMME
SCHEMBL6092218 0.83 LTA4H (0.54) LTA4HMMEACEANPEPECE1
SCHEMBL18697078 0.82 SLC1A3 (0.60) SLC1A3SLC1A2SLC1A1LTA4HMME
SCHEMBL7475872 0.82 SLC1A3 (0.60) SLC1A3SLC1A2SLC1A1LTA4HMME
SCHEMBL7462670 0.82 SLC1A3 (0.60) SLC1A3SLC1A2SLC1A1LTA4HMME
SCHEMBL29459620 0.81 CAPN1 (0.46) SLC1A3SLC1A2SLC1A1CCR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590273-B2 Stabilized glycoside hydrolase variants NOVOZYMES A/S (DK) 2026-03-31 — — US disclosed
US-12391934-B2 Stabilized cellulase variants NOVOZYMES A/S (DK) 2025-08-19 — — US disclosed
EP-3953463-B1 STABILIZED GLYCOSIDE HYDROLASE VARIANTS NOVOZYMES AS (DK) 2025-08-06 — — EP disclosed
US-20250084394-A1 STABILIZED CELLULASE VARIANTS NOVOZYMES A/S (DK) 2025-03-13 — — US disclosed
US-12129498-B2 Stabilized endoglucanase variants NOVOZYMES A/S (DK) 2024-10-29 — — US disclosed
US-20230295591-A1 STABILIZED CELLULASE VARIANTS NOVOZYMES A/S (DK) 2023-09-21 — — US disclosed
US-20230287380-A1 STABILIZED CELLULASE VARIANTS NOVOZYMES A/S (DK) 2023-09-14 — — US disclosed
US-11661592-B2 Stabilized endoglucanase variants NOVOZYMES A/S (DK) 2023-05-30 — — US disclosed
US-20230143128-A1 CARBOHYDRATE BINDING MODULE VARIANTS NOVOZYMES A/S (DK) 2023-05-11 — — US disclosed
US-11566239-B2 Stabilized cellulase variants NOVOZYMES A/S (DK) 2023-01-31 — — US disclosed
US-20220186151-A1 STABILIZED GLYCOSIDE HYDROLASE VARIANTS NOVOZYMES A/S (DK) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143128-A1 CARBOHYDRATE BINDING MODULE VARIANTS MGAM, MANBA, MAN2B1 SLC1A3 4793/4885SLC1A2 4870/4885SLC1A1 4849/4885
US-12590273-B2 Stabilized glycoside hydrolase variants IDUA, IDE, TREH SLC1A3 4541/4885SLC1A2 4674/4885SLC1A1 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.